Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

VIEWPOINTS_Jane Reed_2023
Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines
Shots:  In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry   Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance   Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023
VIEWPOINTS_Micah Litow_2023
Micah Litow shares insights from the 2023 Kalderos Annual Report on drug discount programs
Shots:  Micah Litow, in a stimulating conversation with PharmaShots, shares insights from the 2023 Kalderos Annual Report on drug discount programs   Micah highlights the challenges the drug manufacturers, covered entities, and state payers face on account of US drug discount programs   Micah sheds light on how Kalderos' MDRP Discount Monitoring solution helps drug manufacturers prevent…
November 9, 2023
VIEWPOINTS_Marisa Cruz_2023
Marisa Cruz, in an insightful conversation with PharmaShots, discusses the Empatica Health Monitoring Platform (EHMP)
Shots:  Marisa Cruz, MD, and Chief Medical Officer at Empatica, exchanged thoughts with PharmaShots on the revolutionary Empatica Health Monitoring Platform (EHMP)   Approved by the FDA in Nov’2022, EHMP leverages a cloud-based online portal to collect continuous and seamless physiological data from home and clinical setting   While conversing in great depth about Empatica’s EmbracePlus smartwatch,…
November 2, 2023
VIEWPOINTS_Liz Hurlburt_2023
Liz Hurlburt sheds light on DefenCath, a one of the kind, catheter lock solution
Shots:  Liz Hurlburt, Executive Vice President of Clinical & Medical Affairs at CorMedix discusses the revolutionary prospects of DefenCath, a catheter lock solution to prevent CRBSIs in patients receiving hemodialysis via. CVC   Liz sheds light on a serious unmet need for patients affected with catheter-related bloodstream infections. CRBSIs affect approximately 250,000 people annually who receive…
October 31, 2023
VIEWPOINTS_Catherine Liao_2023
A stirring conversation between Catherine Liao and PharmaShots on SphygmoCor Technology
Shots:  Catherine Liao, Chief Strategy Officer of CardieX, discusses the recent partnership between CardieX’s subsidiary ATCOR and Datacubed Health   Catherine delves deep into the growing dependence on decentralized clinical trials in the healthcare community and cites a few challenges in the study that come with it   Catherine stresses the potential of SphygmoCor technology while discussing…
October 30, 2023
VIEWPOINTS_Kyle Forcier_2023
In a gripping conversation with PharmaShots, Kyle Forcier addresses the ways to avoid the challenges of the 340B program
Shots:  Kyle Forcier, Sr. Director of Life Science Product Marketing at Model N, addresses the challenges of the 340B program and ways manufacturers can mitigate them and emerge stronger   340B, a US federal government plan, enables eligible healthcare organizations and covered entities to receive outpatient drugs from drug manufacturers at significantly low prices   Kyle recalls…
October 23, 2023
VIEWPOINTS_Björn Mellgård_2023
Björn Mellgård shares insights from the Pivotal Phase III data of TAK-755 for congenital thrombotic thrombocytopenic purpura (cTTP)
Shots:  Björn Mellgård Vice President and Global Program Lead, TTP Program, Takeda, shares insights from the P-III data of TAK-755 for the treatment of cTTP   Björn eloquently shares the highlights of the study design for TAK-755, safety and efficacy outcomes, and goes on to share an update from the P-IIIb continuation trial evaluating TAK-755   With…
October 19, 2023
Load more